Diagnosis, Treatment and Prevention of Leprosy
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Diagnostic Microbiology and Infectious Disease".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 1767
Special Issue Editor
Interests: leprosy; early diagnosis; molecular methods; Q PCR, ELISA
Special Issue Information
Dear Colleagues,
Diagnostics in infectious diseases is in the midst of a technological revolution. Recent advances in technology have given rise to a number of host- and pathogen-based diagnostic approaches. Rapid diagnostics promises to improve clinical care in acute and chronic infectious diseases by ensuring that patients receive prompt and effective treatment, while promoting public health by reducing the usage of unnecessary antibiotics when they are not required. Leprosy is a worldwide health problem that necessitates the development of new and innovative management strategies. Early diagnosis of leprosy is a critical step in reducing the spread and incidence of the disease. Therefore, the development of molecular and immunological platforms, including the mapping of antigens, which have potential to be used as immunodiagnostics and molecular tools for the detection of Mycobacterium leprae, is an important approach to confirming clinical diagnosis. In addition to ELISA, molecular tests aid in the identification of specific M. leprae sequences in clinical samples, which can be amplified through the polymerase chain reaction technique, allowing DNA detection of the infectious agent, or with Q PCR technology, which allows the evaluation of viable bacterial load and the monitoring of drug resistance. While this progress is encouraging, it is unlikely that any single diagnostic platform will fully address clinicians’ need for actionable data with short turn-around times in all settings. Thus, a variety of diagnostic tests will ultimately be employed in clinical microbiology laboratories to fully capitalize upon the promise of novel diagnostic approaches.
Dr. Mallika Lavania
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mycobacterium leprae
- molecular diagnosis
- PCR
- early diagnosis
- point of care
- ELISA
- transmission
- serological methods
